These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8032960)

  • 1. Phase II evaluation of amonafide in advanced sarcoma: a Southwest Oncology Group study.
    Buys SS; Metch B; Balcerzak SP; Neefe JR; Stuckey WJ
    Cancer Invest; 1994; 12(4):399-402. PubMed ID: 8032960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of amonafide in advanced and recurrent sarcoma patients.
    Perez RP; Nash SL; Ozols RF; Comis RL; O'Dwyer PJ
    Invest New Drugs; 1992 Jul; 10(2):99-101. PubMed ID: 1500272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amonafide as first-line chemotherapy for metastatic breast cancer.
    Kornek G; Raderer M; Depisch D; Haider K; Fazeny B; Dittrich C; Scheithauer W
    Eur J Cancer; 1994; 30A(3):398-400. PubMed ID: 8204367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II trial of amonafide in advanced pancreas cancer. A Southwest Oncology Group study.
    Leichman CG; Tangen C; Macdonald JS; Leimert T; Fleming TR
    Invest New Drugs; 1993; 11(2-3):219-21. PubMed ID: 8262735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of amonafide in patients with advanced metastatic or recurrent endometrial adenocarcinoma. A Southwest Oncology Group study.
    Malviya VK; Liu PY; O'Toole R; Alberts DS; Surwit E; Rosenoff S; Ward JH; Yu A; O'Sullivan J; Craig JB
    Am J Clin Oncol; 1994 Feb; 17(1):37-40. PubMed ID: 8311005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II trial of amonafide in patients with endometrial cancer: a Gynecologic Oncology Group Study.
    Asbury R; Blessing JA; Reid GC; McGuire WP
    Am J Clin Oncol; 1998 Aug; 21(4):406-7. PubMed ID: 9708643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of amonafide in disseminated malignant melanoma. A Southwest Oncology Group study.
    Slavik M; Kopecky KJ; Sondak V; Craig JB; Samson MK
    Invest New Drugs; 1993; 11(2-3):223-6. PubMed ID: 8262736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of amonafide for the treatment of advanced, hormonally refractory carcinoma of the prostate. A Southwest Oncology Group study.
    Marshall ME; Blumenstein B; Crawford ED; Thompson IM; Craig JB; Eisenberger M; Ahmann F
    Am J Clin Oncol; 1994 Dec; 17(6):514-5. PubMed ID: 7977172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amonafide in patients with leiomyosarcoma of the uterus: a phase II Gynecologic Oncology Group study.
    Asbury R; Blessing JA; Buller R; Malfetano JH; Walker J; Sevin BU
    Am J Clin Oncol; 1998 Apr; 21(2):145-6. PubMed ID: 9537200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of amonafide in advanced pancreatic adenocarcinoma.
    Linke K; Pazdur R; Abbruzzese JL; Ajani JA; Winn R; Bradof JE; Daugherty K; Levin B
    Invest New Drugs; 1991 Nov; 9(4):353-6. PubMed ID: 1804812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of amonafide (nafidamide, NSC 308847) in advanced colorectal cancer.
    O'Dwyer PJ; Paul AR; Hudes GR; Walczak J; Ozols RF; Comis RL
    Invest New Drugs; 1991 Feb; 9(1):65-7. PubMed ID: 2026485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II trial of amonafide in patients with mixed mesodermal tumors of the uterus: a Gynecologic Oncology Group study.
    Asbury R; Blessing JA; Podczaski E; Ball H
    Am J Clin Oncol; 1998 Jun; 21(3):306-7. PubMed ID: 9626805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of amonafide in advanced breast cancer.
    Scheithauer W; Dittrich C; Kornek G; Haider K; Linkesch W; Gisslinger H; Depisch D
    Breast Cancer Res Treat; 1991 Dec; 20(1):63-7. PubMed ID: 1813070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642).
    Costanza ME; Berry D; Henderson IC; Ratain MJ; Wu K; Shapiro C; Duggan D; Kalra J; Berkowitz I; Lyss AP
    Clin Cancer Res; 1995 Jul; 1(7):699-704. PubMed ID: 9816035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of amonafide in advanced colorectal cancer: a SouthWest Oncology Group study.
    Brown TD; Goodman PJ; Fleming T; Macdonald JS; Craig JB; Einstein AB
    Anticancer Drugs; 1993 Feb; 4(1):49-50. PubMed ID: 8457714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of amonafide in the treatment of patients with advanced squamous cell carcinoma of the head and the neck. An Illinois Cancer Center study.
    Rosen F; Vokes EE; Lad T; Kies M; Wade J; Kilton LJ; Blough R; French S; Mullane M; Benson AB
    Invest New Drugs; 1995; 13(3):249-52. PubMed ID: 8729954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized phase II trial of amonafide or trimetrexate in patients with advanced non-small cell lung cancer. A trial of the North Central Cancer Treatment Group.
    Gesme DH; Jett JR; Schreffler DD; Su JQ; Mailliard JA; Foley JF; Krook JE; Maksymiuk AW; Hatfield AK; Ebbert LP
    Cancer; 1993 May; 71(9):2723-6. PubMed ID: 8385564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I clinical investigation of amonafide.
    Saez R; Craig JB; Kuhn JG; Weiss GR; Koeller J; Phillips J; Havlin K; Harman G; Hardy J; Melink TJ
    J Clin Oncol; 1989 Sep; 7(9):1351-8. PubMed ID: 2549205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ECOG phase II study of amonafide in unresectable or recurrent carcinoma of the head and neck (PB390). Eastern Cooperative Oncology Group.
    Leaf AN; Neuberg D; Schwartz EL; Wadler S; Ritch PS; Dutcher JP; Adams GL
    Invest New Drugs; 1997; 15(2):165-72. PubMed ID: 9220297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Gynecologic Oncology Group phase II study of amonafide (NSC #308847) in squamous cell carcinoma of the cervix.
    Asbury RF; Blessing JA; Soper JT
    Am J Clin Oncol; 1994 Apr; 17(2):125-8. PubMed ID: 8141104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.